Lv63
3150 积分 2025-06-06 加入
中国女性乳腺癌患者糖尿病和糖尿病前期管理专家共识（2024版）
10个月前
已关闭
中国女性乳腺癌患者糖尿病和糖尿病前期管理专家共识（2024版）
10个月前
已完结
Management Strategies for Hyperglycemia Associated with the α-Selective PI3K Inhibitor Alpelisib for the Treatment of Breast Cancer
10个月前
已完结
[Chinese expert consensus on metformin in clinical practice: 2023 update]
10个月前
已完结
Management of Phosphatidylinositol-3-Kinase Inhibitor-Associated Hyperglycemia
10个月前
已关闭
Inavolisib-Based Therapy in PIK3CA -Mutated Advanced Breast Cancer
10个月前
已完结
Management of Phosphatidylinositol-3-Kinase Inhibitor-Associated Hyperglycemia
10个月前
已关闭
Management Strategies for Hyperglycemia Associated with the α-Selective PI3K Inhibitor Alpelisib for the Treatment of Breast Cancer
10个月前
已完结
Management Strategies for Hyperglycemia Associated with the α-Selective PI3K Inhibitor Alpelisib for the Treatment of Breast Cancer
10个月前
已关闭
Chinese expert consensus on management of diabetes and prediabetes in female breast cancer patients (version 2024)
10个月前
已关闭
皖公网安备34019202002308
